Despite earlier research suggesting that metformin prescribed to treat type 2 diabetes might confer some level of protection against severe COVID-19, a recent study finds that the most commonly prescribed glucose-lowering agent has no influence on either susceptibility to or outcomes from infection with novel coronavirus.